Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Active surveillance has been introduced as a management option for low-risk papillary thyroid microcarcinoma (PTMC) due to its mostly indolent course. METHODS: This was a multicenter study of 370 PTMC patients who underwent active surveillance more than one year. The changes in volume and maximum diameter between initial and last ultrasonography were evaluated to identify the natural course of PTMC during active surveillance. RESULTS: , respectively. During the median 32.5 months of follow-up, 86 (23.2%) patients were found to have an increase in tumor volume, and 13 (3.5%) patients showed an increase in the maximal diameter of the tumor. The cumulative incidence of volume increase gradually rose with time (6.9%, 17.3%, 28.2%, and 36.2% after two, three, four, and five years, respectively). The risk of volume increase in patients <45 years of age was twice as high as in older patients (p = 0.002). There was no significant difference in tumor size change according to sex, levothyroxine treatment, or presence of Hashimoto's thyroiditis. During the period, 58 (15.7%) patients underwent delayed thyroid surgery due to anxiety (37.9%), tumor size increase (32.8%), or appearance of cervical lymph node metastasis (8.6%). Lymph node metastasis was found in 29.3% of patients on pathological examination. CONCLUSIONS: A significant number of PTMCs grow during active surveillance, and tumor volume change is a more sensitive means of evaluating tumor growth. Active surveillance can be carefully applied for selected patients. Although it is not contraindicated, it should be applied more cautiously for younger patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
The 2017 Bethesda System for Reporting Thyroid Cytopathology
Cibas, E. S., & Ali, S. Z. (2017) · Thyroid · doi:10.1089/thy.2017.0500 · Cited by 1,844 · cited 2×
“FNAC diagnoses were classified into six categories according to the Bethesda System (13), and CNB specimens were evaluated on the basis of the criteria proposed by the Korean Endocrine Pathology Thyroid CNB Study Group (14).”
Russ, G., Bonnema, S. J., Erdogan, M. F., Durante, C., Ngu, R., & Leenhardt, L. (2017) · European Thyroid Journal · doi:10.1159/000478927 · Cited by 1,284
Rosato, L., Avenia, N., Bernante, P., De Palma, M., Gulino, G., Nasi, P. G., Pelizzo, M. R., & Pezzullo, L. (2004) · World Journal of Surgery · doi:10.1007/s00268-003-6903-1 · Cited by 902 · cited 1×
“…surgery is much lower in thyroid cancer: the incidence of major complications after prostate cancer surgery (impo-tence and urinary incontinence) can exceed 50%, while the incidence of major complications in thyroid cancer (voice alterations and hypoparathyroidism) tend to be 10% (31,32).”
Shin, J. H., Baek, J. H., Chung, J., Ha, E. J., Kim, J.-H., Lee, Y. H., Lim, H. K., Moon, W.-J., Na, D. G., Park, J. S., et al. (2016) · Korean Journal of Radiology · doi:10.3348/kjr.2016.17.3.370 · Cited by 889 · cited 1×
“PTMC was diagnosed with US-guided FNAC or CNB, according to published criteria (16,17).”
Self-citationIto, Y., Uruno, T., Nakano, K., Takamura, Y., Miya, A., Kobayashi, K., Yokozawa, T., Matsuzuka, F., Kuma, S., Kuma, K., et al. (2003) · Thyroid · doi:10.1089/105072503321669875 · Cited by 877 · cited 4×
“Active surveillance of thyroid cancer was first introduced by a Japanese group, who suggested that this is generally safe (4,5).”
InfluentialIto, Y., Miyauchi, A., Kihara, M., Higashiyama, T., Kobayashi, K., & Miya, A. (2014) · Thyroid · doi:10.1089/thy.2013.0367 · Cited by 826 · cited 4×
“Active surveillance of thyroid cancer was first introduced by a Japanese group, who suggested that this is generally safe (4,5).”
InfluentialAn Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients
Ito, Y., Miyauchi, A., Inoue, H., Fukushima, M., Kihara, M., Higashiyama, T., Tomoda, C., Takamura, Y., Kobayashi, K., & Miya, A. (2010) · World Journal of Surgery · doi:10.1007/s00268-009-0303-0 · Cited by 811 · cited 1×
“Previous Japanese studies have evaluated tumor size increase using the maximal increase in diameter ia mm as the criterion, which is now regarded as a surgical indication during active surveillance (4–6).”
Cited by
Ringel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K., & Haymart, M. R. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00020-x · Cited by 590
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., Angelos, P., Chen, H., Doherty, G. M., Fahey, T. J., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003580 · Cited by 541
Sugitani, I., Ito, Y., Takeuchi, D., Nakayama, H., Masaki, C., Shindo, H., Teshima, M., Horiguchi, K., Yoshida, Y., Kanai, T., et al. (2021) · Thyroid · doi:10.1089/thy.2020.0330 · Cited by 388
Metadata
- Authors
- Oh, H.-S., Ha, J., Kim, H. I., Kim, T. H., Kim, W. G., Lim, D.-J., Kim, T. Y., Kim, S. W., Kim, W. B., Shong, Y. K., Chung, J. H., & Baek, J. H.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2018-12
- Volume
- 28
- Issue
- 12
- Pages
- 1587-1594
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W2891653457
- Cited by
- 205
- References
- 32
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.